Testing effectiveness (Phase 2)Study completedNCT03358030
What this trial is testing
ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis
Who this might be right for
End-stage Renal Disease (ESRD)
Ionis Pharmaceuticals, Inc. 213